Literature DB >> 11135507

Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State.

P W Appel1, H Joseph, A Kott, W Nottingham, E Tasiny, E Habel.   

Abstract

The New York State Office of Alcoholism and Substance Abuse Services (OASAS) licenses the largest system of methadone maintenance clinics nationwide. In 1996, a survey was undertaken to evaluate the functioning of patients continuously active in treatment for ten or more years. Information was obtained on a 10% random sample from the OASAS client data system and the records of the clinics. Data were collected concerning methadone dose, illicit drug and problematic alcohol use, employment, criminal activity, health, living situations, and the primary type of payment for treatment. A contrast group was constructed of discharged patients who had no more than 5 years of continuous treatment. The long-term active patients in the study sample showed superior outcomes on all variables, although some of the differences were small. However, the arrest rate for the discharged contrast group was 20 times as large as the arrest rate for the active study sample. These results are consistent with nationwide evaluations of methadone maintenance treatment. Factors that negatively impacted on the adjustments of the active patients were heavy use of crack/cocaine and disabilities. The long-term active patients in this sample belong to distinct subgroups with different levels of functioning, achievement, and ongoing health and social needs that must be investigated and addressed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135507

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  9 in total

1.  Substance abuse treatment effectiveness of publicly funded clients in Tennessee.

Authors:  Satish Kedia; Stephanie W Perry
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

2.  The impact of financial discharge from methadone maintenance therapy on incarceration.

Authors:  Nickolas D Zaller; Jeannia J Fu; Alexander R Bazazi; Josiah D Rich
Journal:  J Opioid Manag       Date:  2010 Sep-Oct

3.  Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.

Authors:  Jeannia J Fu; Nickolas D Zaller; Michael A Yokell; Alexander R Bazazi; Josiah D Rich
Journal:  J Subst Abuse Treat       Date:  2013-02-22

4.  Health consequences of long-term injection heroin use among aging Mexican American men.

Authors:  Luis R Torres; Charles Kaplan; Avelardo Valdez
Journal:  J Aging Health       Date:  2011-03-30

5.  Alcohol and opiate withdrawal in US jails.

Authors:  Kevin Fiscella; Naomi Pless; Sean Meldrum; Paul Fiscella
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

6.  Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.

Authors:  Helena B Hansen; Carole E Siegel; Brady G Case; David N Bertollo; Danae DiRocco; Marc Galanter
Journal:  J Behav Health Serv Res       Date:  2013-07       Impact factor: 1.505

7.  Jail management of arrestees/inmates enrolled in community methadone maintenance programs.

Authors:  Kevin Fiscella; Andrew Moore; Judith Engerman; Sean Meldrum
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

Review 8.  Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis.

Authors:  Hua-Min Sun; Xiao-Yan Li; Eric P F Chow; Tong Li; Yun Xian; Yi-Hua Lu; Tian Tian; Xun Zhuang; Lei Zhang
Journal:  BMJ Open       Date:  2015-01-08       Impact factor: 2.692

9.  Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients.

Authors:  David Medved; Thomas Clausen; Anne Bukten; Ronny Bjørnestad; Ashley Elizabeth Muller
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-11-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.